Austco Healthcare Ltd engages in the development and provision of electronic communications and clinical management solutions. It offers Tacera, a nurse call, and healthcare communication system for healthcare professionals and patient. The group is segmented into four geographic regions consisting of Australia/New Zealand, Asia, Europe, and North America.
2004
102
LTM Revenue $57.0M
LTM EBITDA $9.5M
$80.5M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
As of August 2025, Austco Healthcare reported last 12-month revenue of $57.0M and EBITDA of $9.5M.
In the same period, Austco Healthcare achieved $4.7M in LTM net income.
See Austco Healthcare valuation multiples based on analyst estimatesIn the most recent fiscal year, Austco Healthcare reported revenue of $53.3M and EBITDA of $7.2M.
Austco Healthcare expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Austco Healthcare valuation multiples based on analyst estimatesLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue | $57.0M | XXX | $53.3M | XXX | XXX | XXX |
Gross Profit | n/a | XXX | $27.8M | XXX | XXX | XXX |
Gross Margin | n/a | XXX | 52% | XXX | XXX | XXX |
EBITDA | $9.5M | XXX | $7.2M | XXX | XXX | XXX |
EBITDA Margin | 17% | XXX | 13% | XXX | XXX | XXX |
EBIT | $7.6M | XXX | $6.6M | XXX | XXX | XXX |
EBIT Margin | 13% | XXX | 12% | XXX | XXX | XXX |
Net Profit | $4.7M | XXX | $3.9M | XXX | XXX | XXX |
Net Margin | 8% | XXX | 7% | XXX | XXX | XXX |
Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Austco Healthcare has current market cap of AUD 133M (or $87.4M), and EV of AUD 123M (or $80.5M).
As of September 19, 2025, Austco Healthcare's stock price is AUD 0 (or $0).
See Austco Healthcare trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$80.5M | $87.4M | XXX | XXX | XXX | XXX | $0.01 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAustco Healthcare's trades at 1.8x EV/Revenue multiple, and 13.0x EV/EBITDA.
See valuation multiples for Austco Healthcare and 15K+ public compsAs of September 19, 2025, Austco Healthcare has market cap of $87.4M and EV of $80.5M.
Equity research analysts estimate Austco Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Austco Healthcare has a P/E ratio of 18.4x.
LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $87.4M | XXX | $87.4M | XXX | XXX | XXX |
EV (current) | $80.5M | XXX | $80.5M | XXX | XXX | XXX |
EV/Revenue | 1.4x | XXX | 1.8x | XXX | XXX | XXX |
EV/EBITDA | 8.5x | XXX | 13.0x | XXX | XXX | XXX |
EV/EBIT | 10.7x | XXX | 15.5x | XXX | XXX | XXX |
EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
P/E | 18.4x | XXX | 20.5x | XXX | XXX | XXX |
EV/FCF | 29.0x | XXX | 15.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAustco Healthcare's last 12 month revenue growth is 25%
Austco Healthcare's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.2M for the same period.
Austco Healthcare's rule of 40 is 39% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Austco Healthcare's rule of X is 80% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Austco Healthcare and other 15K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | 25% | XXX | 27% | XXX | XXX | XXX |
EBITDA Margin | 17% | XXX | 14% | XXX | XXX | XXX |
EBITDA Growth | 39% | XXX | 48% | XXX | XXX | XXX |
Rule of 40 | 39% | XXX | 39% | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | 80% | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $0.5M | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 40% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Philips | XXX | XXX | XXX | XXX | XXX | XXX |
Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Austco Healthcare acquired XXX companies to date.
Last acquisition by Austco Healthcare was XXXXXXXX, XXXXX XXXXX XXXXXX . Austco Healthcare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free TrialWhen was Austco Healthcare founded? | Austco Healthcare was founded in 2004. |
Where is Austco Healthcare headquartered? | Austco Healthcare is headquartered in Australia. |
How many employees does Austco Healthcare have? | As of today, Austco Healthcare has 102 employees. |
Is Austco Healthcare publicy listed? | Yes, Austco Healthcare is a public company listed on ASX. |
What is the stock symbol of Austco Healthcare? | Austco Healthcare trades under AHC ticker. |
When did Austco Healthcare go public? | Austco Healthcare went public in 2004. |
Who are competitors of Austco Healthcare? | Similar companies to Austco Healthcare include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
What is the current market cap of Austco Healthcare? | Austco Healthcare's current market cap is $87.4M |
What is the current revenue of Austco Healthcare? | Austco Healthcare's last 12 months revenue is $57.0M. |
What is the current revenue growth of Austco Healthcare? | Austco Healthcare revenue growth (NTM/LTM) is 25%. |
What is the current EV/Revenue multiple of Austco Healthcare? | Current revenue multiple of Austco Healthcare is 1.4x. |
Is Austco Healthcare profitable? | Yes, Austco Healthcare is EBITDA-positive (as of the last 12 months). |
What is the current EBITDA of Austco Healthcare? | Austco Healthcare's last 12 months EBITDA is $9.5M. |
What is Austco Healthcare's EBITDA margin? | Austco Healthcare's last 12 months EBITDA margin is 17%. |
What is the current EV/EBITDA multiple of Austco Healthcare? | Current EBITDA multiple of Austco Healthcare is 8.5x. |
What is the current FCF of Austco Healthcare? | Austco Healthcare's last 12 months FCF is $2.8M. |
What is Austco Healthcare's FCF margin? | Austco Healthcare's last 12 months FCF margin is 5%. |
What is the current EV/FCF multiple of Austco Healthcare? | Current FCF multiple of Austco Healthcare is 29.0x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.